Drug Trial Radar · NCT03054870
A Comparison of Technegas and Xenon-133 Planar Lung Imaging in Subjects Referred for Ventilation Scintigraphy
Last checked: Nov 19, 2026Latest source record: Sep 24, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
226
Actual
Start
Sep 1, 2017
Primary completion
Sep 18, 2020
Study completion Nov 23, 2020
Sponsor
- Lead sponsor
- Cyclomedica Australia PTY LimitedIndustry
- Sponsor type
- Industry
- First posted
- Feb 16, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 3 within-subject non-inferiority trial of Technegas ventilation imaging compared to Xenon-133 (Xe-133) ventilation imaging to demonstrate the non-inferiority of Technegas compared to Xe-133 ventilation studies with respect to subject pulmonary ventilatory distribution. Subjects will undergo site-specific standard of care (SOC) Xe-133 imaging per medical needs followed by Technegas ventilation imaging per study protocol.
Conditions
- Lung Structure Determination
Interventions
Xe-133Drug
Xe-133 ventilation scintigraphy
TechnegasDrug
Technegas ventilation scintigraphy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blinded Readers Percent Agreement (PA) for Matching Image ViewsTime frame: The median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Morton Plant Hospital
Clearwater, Florida
Mayo Clinic in Jacksonville, FL
Jacksonville, Florida
Loyola University Medical Center
Maywood, Illinois
Washington University Medical Center, Barnes-Jewish Hospital - Center for Advanced Medicine
St Louis, Missouri
Duke University Hospital
Durham, North Carolina
University of Texas Southwestern Medical Center
Dallas, Texas
Houston Methodist Hospital
Houston, Texas
Scott & White Medical Center
Temple, Texas
University of Utah Health Science Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.